Table 3 Demographic and clinical details of the cohort. Data are mean (SD) unless otherwise specified
|  | Cohort (n = 20) | Intervention (n = 10) | Control (n = 10) |
|---|---|---|---|
Age | 57.5 (11.2) | 54.6 (8.9) | 60.3 (12.9) |
Male, n (%) | 18 (90) | 10 (100) | 8 (80) |
Diagnosis | |||
 - Ischaemic stroke, n (%) | 16 (80) | 6 (60) | 10 (100) |
 - Haemorrhagic stroke, n (%) | 4 (20) | 4 (40) | 0 (0) |
Stroke location | |||
 - Right-side lesion n (%) | 10 (50) | 2 (20) | 8 (80) |
NIHSS, median (IQR)a | 3.0 (2–5) | 3.5 (2–5) | 2.5 (1–4) |
mRS, median (IQR) | 2.0 (1–2) | 2.0 (1–2) | 2.0 (1–3) |
Beta-blocker usage, n (%) | 2 (10) | 0 (0) | 2 (20) |
Diabetes, n (%) | 4 (20) | 2 (20) | 2 (20) |
Time to recruitment (days), median (IQR) | |||
 - From stroke date | 109.5 (72–175) | 88.0 (65–155) | 128.5 (88–225) |
 - From CBR admission | 41.5 (21–89) | 48.5 (17–86) | 41.0 (22–119) |
Trial session attendance, mean (SD) | 19 (3.6) | 17.9 (4.4) | 20 (2.5) |
Interpreter required, n (%) | 5 (25) | 3 (30) | 2 (20) |